Advertisement

Index by author

October 01, 1995; Volume 275,Issue 1

  1. Danhof, M

    1. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
      R A Mathôt, J M Gubbens-Stibbe, W Soudijn, K A Jacobson, A P Ijzerman and M Danhof
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 245-253;

  2. Dement, W C

    1. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
      W F Seidel, M Maze, W C Dement and D M Edgar
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 263-273;

  3. De Waele, J P

    1. Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats.
      J P de Waele, K Kiianmaa and C Gianoulakis
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 518-527;

  4. Dirig, D M

    1. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model.
      D M Dirig and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 219-227;

  5. Doods, H N

    1. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
      H N Doods, W Wienen, M Entzeroth, K Rudolf, W Eberlein, W Engel and H A Wieland
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 136-142;
    2. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
      H A Wieland, K D Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and H N Doods
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 143-149;

  6. Eberlein, W

    1. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
      H N Doods, W Wienen, M Entzeroth, K Rudolf, W Eberlein, W Engel and H A Wieland
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 136-142;
    2. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
      H A Wieland, K D Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and H N Doods
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 143-149;

  7. Edgar, D M

    1. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
      W F Seidel, M Maze, W C Dement and D M Edgar
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 263-273;

  8. Elliott, J D

    1. Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.
      M Gellai, M Jugus, T Fletcher, P Nambi, E H Ohlstein, J D Elliott and D P Brooks
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 200-206;

  9. Engel, W

    1. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
      H N Doods, W Wienen, M Entzeroth, K Rudolf, W Eberlein, W Engel and H A Wieland
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 136-142;
    2. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
      H A Wieland, K D Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and H N Doods
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 143-149;

  10. Entzeroth, M

    1. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
      H N Doods, W Wienen, M Entzeroth, K Rudolf, W Eberlein, W Engel and H A Wieland
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 136-142;
    2. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
      H A Wieland, K D Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and H N Doods
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 143-149;
« Previous (Pages : 1 2 3 4 5 6 7 8 9 10 ... 27) Next »
Back to top

In this issue

Advertisement